Sinha Sanjay, Heagerty Anthony M, Shuttleworth C Adrian, Kielty Cay M
Wellcome Trust Centre for Cell-Matrix Research, 2.205 Stopford Building, University of Manchester, Manchester M13 9PT, UK.
Cardiovasc Res. 2002 Mar;53(4):971-83. doi: 10.1016/s0008-6363(01)00512-0.
Transforming growth factor-beta (TGF-beta), a potent regulator of wound healing and scar formation, is thought to have a key role in the response to arterial injury. Latent TGF-beta binding proteins (LTBPs), members of the fibrillin superfamily, govern TGF-beta1 release, targeting and activation in vitro and also play a role as structural components of fibrillin-rich microfibrils. Despite the potential of LTBPs to modulate the response to arterial injury through either or both of these mechanisms, as yet their expression and function in the injured vasculature remain poorly defined.
In this study, a porcine model of coronary angioplasty was used to investigate LTBP-1 and LTBP-2 synthesis and their association with TGF-beta 1 and fibrillin-1.
After angioplasty, increased LTBP-1 and LTBP-2 immunostaining was detected in a similar distribution to increased TGF-beta 1 expression in the neointima and in the neoadventitia. Overnight organ cultures revealed the formation of large latent TGF-beta 1 complexes containing LTBP-1. Increased LTBP-1 proteolysis after arterial injury correlated with increased active and latent TGF-beta levels. LTBP-2 synthesis increased in response to arterial injury but was neither present in large latent complexes nor proteolytically processed. LTBP-1 and LTBP-2 both co-localised to fibrillin-rich fibrillar structures in the neointima and adventitia.
These data suggest that LTBP-1 may have a TGF-beta 1 binding role in the arterial response to injury, and that LTBP-1 and LTBP-2 may have a structural role in association with microfibrils within the developing neointimal lesion. LTBP-1 proteolysis is potentially an important regulatory step for TGF-beta activation in the vasculature and inhibition of proteolysis could represent a novel therapeutic modality for controlling the arterial injury response.
转化生长因子-β(TGF-β)是伤口愈合和瘢痕形成的强效调节剂,被认为在动脉损伤反应中起关键作用。潜在TGF-β结合蛋白(LTBP)是原纤维蛋白超家族成员,在体外调控TGF-β1的释放、靶向及激活,还作为富含原纤维蛋白的微原纤维的结构成分发挥作用。尽管LTBP有潜力通过上述一种或两种机制调节动脉损伤反应,但它们在受损脉管系统中的表达和功能仍不清楚。
本研究采用猪冠状动脉成形术模型,研究LTBP-1和LTBP-2的合成及其与TGF-β1和原纤维蛋白-1的关系。
血管成形术后,在新生内膜和新生外膜中,LTBP-1和LTBP-2免疫染色增加,其分布与TGF-β1表达增加相似。过夜器官培养显示形成了含LTBP-1的大的潜在TGF-β1复合物。动脉损伤后LTBP-1蛋白水解增加与活性和潜在TGF-β水平升高相关。LTBP-2合成因动脉损伤而增加,但不存在于大的潜在复合物中,也未发生蛋白水解加工。LTBP-1和LTBP-2均共定位于新生内膜和外膜中富含原纤维蛋白的纤维状结构。
这些数据表明,LTBP-1可能在动脉损伤反应中具有结合TGF-β1的作用,并且LTBP-1和LTBP-2可能在发育中的新生内膜病变内与微原纤维相关联而发挥结构作用。LTBP-1蛋白水解可能是脉管系统中TGF-β激活的重要调控步骤,抑制蛋白水解可能代表一种控制动脉损伤反应的新治疗方式。